biostudies-literatureUnknown32(2)Aitken CARijksinstituut voor Volksgezondheid en Milieu<h4>Background</h4>In the Netherlands, lower high-risk human papillomavirus (hrHPV) positivity but higher cervical intraepithelial neoplasia (CIN) 2+ detection were found in self-collected compared with clinician-collected samples. To investigate the possible reason for these differences, we compared sociodemographic and screening characteristics of women and related these to screening outcomes.<h4>Methods</h4>We extracted data from PALGA on all primary hrHPV screens and associated follow-up tests for 857,866 screened women, invited in 2017 and 2018. We linked these data with sociodemographic data from Statistics Netherlands. Logistic regression was performed for hrHPV positivity and CIN 2+/3+ detection.<h4>Results</h4>Out of the 857,866 women, 6.8% chose to use a self-sampling device. A hCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology183-192https://www.ebi.ac.uk/biostudies/studies/S-EPMC9900317biostudies-literatureSociodemographic Characteristics and Screening Outcomes of Women Preferring Self-Sampling in the Dutch Cervical Cancer Screening Programme: A Population-Based Study.PMC9900317Inturrisi Fde Kok IMCMKaljouw Svan Kemenade FJNiesters HGMBerkhof JHinrichs JWJAitken CAMolijn ANieboer DMelchers WJGSiebers AGvan den Brule AJCfalseSociodemographic Characteristics and Screening Outcomes of Women Preferring Self-Sampling in the Dutch Cervical Cancer Screening Programme: A Population-Based Study.<h4>Background</h4>In the Netherlands, lower high-risk human papillomavirus (hrHPV) positivity but higher cervical intraepithelial neoplasia (CIN) 2+ detection were found in self-collected compared with clinician-collected samples. To investigate the possible reason for these differences, we compared sociodemographic and screening characteristics of women and related these to screening outcomes.<h4>Methods</h4>We extracted data from PALGA on all primary hrHPV screens and associated follow-up tests for 857,866 screened women, invited in 2017 and 2018. We linked these data with sociodemographic data from Statistics Netherlands. Logistic regression was performed for hrHPV positivity and CIN 2+/3+ detection.<h4>Results</h4>Out of the 857,866 women, 6.8% chose to use a self-sampling device. A h2023-01-01T00:00:00Z2023 Feb2025-04-22T12:38:16.998Z2025-04-06T00:20:38.119ZS-EPMC99003173609941610.1158/1055-9965.EPI-22-0712